Kathy Boltz, PhD

Most Recent Articles by Kathy Boltz, PhD

Suicides Significantly Higher Among Patients With Head and Neck Cancers

Patients with head and neck cancer have more than 3 times the incidence of suicide compared with the general population, with rates highest among patients with cancers of the larynx and hypopharynx.

Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme

Researchers identified propentofylline as a drug that could help treat patients with the deadly brain cancer glioblastoma multiforme.

Cause of a Childhood Kidney Cancer Is a Previously Unrecognized Role of a Known Gene

Genetic mutations in the REST gene have been shown to cause Wilms tumor, a rare kidney cancer that occurs in children. The findings identified mutations in the REST gene in 16 children with Wilms tumor.

Personalized Antinausea Regimens More Effective in Cancer Patients Receiving Emetogenic Chemotherapy

A personalized approach to treating nausea and vomiting, the most expected side effects of chemotherapy, is far more effective than the existing one-size-fits-all guidelines.

Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment

Scientists developed a highly sensitive blood test that indicates when breast cancers become resistant to standard hormone treatment. In addition, the test results can be used to guide further treatment.

More Articles by Kathy Boltz, PhD

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs